What Is The Difference Between THC And CBD?

 Posted by at 8:00 AM on December 21, 2014  Marijuana Science
Dec 212014
 December 21, 2014
What Is The Difference Between THC And CBD?

What Is The Difference Between Tetrahydrocannabinol (THC) And Cannabidiol (CBD)? The cannabis plant contains dozens of cannabinoids. The most well known cannabinoid for a long time has been tetrahydrocannabinol (THC), but as more scientific research is conducted involving cannabis and its ability to be used as a medicine, more and more people are learning about other cannabinoids, expecially cannabidiol (CBD). The last couple of years interest in CBD has grown exponentially, as it’s been featured on numerous television episodes showing how well it works in treating people who suffer from severe epilepsy. One of the most common questions I get asked these days is

Read More
Dec 182014
 December 18, 2014
MAPS Receives $2 Million Grant From Colorado For PTSD Medical Marijuana Study

On Wednesday, December 17, the Colorado Department of Public Health and Environment awarded a $2 million grant to the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) for their planned study of marijuana for symptoms of post traumatic stress disorder (PTSD) in 76 U.S. veterans. Colorado’s Medical Marijuana Scientific Advisory Council recommended that MAPS receive the grant on November 24. Yesterday’s decision followed the Council’s recommendation, giving MAPS the largest of eight grants awarded by CDPHE at Wednesday’s meeting. All of the other grantees are major research universities. “As the very first public funding that MAPS has ever received in our

Read More
Dec 182014
 December 18, 2014
Colorado Approves 8 Million Dollars In Grants For Marijuana Research

Something that marijuana opponents say over and over is ‘they will not support marijuana reform until there is more research done.’ That is usually accompanied by efforts to prevent any marijuana research at any cost. The sad truth is that the last thing marijuana opponents want is for marijuana research to occur because they know that research will prove that marijuana is medicine. The ‘wait for more research’ tactic is just an attempt to delay marijuana reform. The State of Colorado approved 8 million dollars in grants for marijuana research and studies, which I’m sure is something that scares marijuana

Read More
Nov 292014
 November 29, 2014
Colorado: $7.5 Million In Grants For Clinical Cannabis Trials

By Paul Armentano, NORML Deputy Director State Public Health Department officials have recommended over $7 million dollars in grant funding to pay for a series of state-sponsored clinical trials to assess the safety and efficacy of cannabis and cannabinoids. The proposed studies include a pair of clinical trials to evaluate the use of cannabidiol (CBD), a nonpsychotropic plant cannabinoid, for patients with pediatric epilepsy. Two additional trials will assess the use of cannabis for patients suffering from post-traumatic stress. Other studies will assess the efficacy of either cannabis or CBD in the treatment of Parkinson’s disease, brain tumors, ulcerative colitis,

Read More
Nov 262014
 November 26, 2014
Colorado Health Officials Recommend Grants For Marijuana Research

Something you hear marijuana opponents say over and over is that ‘there needs to be more marijuana research conducted’ before they support reform. That of course is usually only a delay tactic, proven by the fact that these same marijuana opponents fight marijuana research efforts as much as possible. I think deep down they know that research will be favorable to the marijuana movement. Fortunately for marijuana supporters, Colorado health officials have announced their recommendations for 8 marijuana research grants. Per the Denver Post: Colorado health officials have recommended funding two studies on childhood epilepsy, two studies on post-traumatic stress

Read More
Nov 242014
 November 24, 2014
Marijuana Rescheduling Tabled By Iowa Pharmacy Board

The fight to reschedule marijuana in Iowa has taken a very long time. When I started this blog, I met a guy named Carl Olsen online who had been fighting for years to get marijuana rescheduled in Iowa, and that fight continues to this day. Last week the Iowa Pharmacy Board was supposed to vote on marijuana rescheduling, but instead chose to punt the idea down the road. Per the Des Moines Register: Three members of the Iowa Board of Pharmacy recommended Wednesday morning that the state take marijuana out of the strictest classification of drugs, but the full board

Read More
Nov 202014
 November 20, 2014
Study: Marijuana Drastically Shrinks Aggressive Form Of Brain Cancer

I hate cancer. Right now I have two family members battling cancer, and it’s a very sad thing. I am confident that they will both win their battle. In the case of my step dad, this is his second battle. I have urged both of them to try marijuana  to compliment their other treatments, and I’m happy to say, both of them are trying it. A new study was recently released that shows marijuana can shrink a very aggressive form of brain cancer. Per the Huffington Post: In a paper published Friday in the journal Molecular Cancer Therapies, a team of

Read More
Nov 152014
 November 15, 2014
NORML Responds To Latest 'Pot Shrinks The Brain' Fears

NORML’s Deputy Director today on Alternet.org addressed new media claims that cannabis use can potentially shrink the brain: [excerpt] A new study identifying minor differences in the brain imaging of habitual marijuana consumers compared to non-users may be ideal for stimulating sensational headlines (e.g., “Regular pot smokers have shrunken brains, study says,” Los Angeles Times, November 10), but tells us little in regard to whether pot poses actual health risks. Specifically, an MRI scan revealed less gray matter in the orbital frontal cortex of pot-smoking subjects compared to those who had never used the drug. Researchers also identified increased connectivity

Read More
Nov 012014
 November 1, 2014
Federal Evidentiary Hearing Regarding Marijuana Scheduling Concludes

By Paul Armentano, NORML Deputy Director United States District Judge Kimberly Mueller heard testimony over the course of the past five days in regard to the constitutionality of the federal statute designating marijuana as a Schedule I Controlled Substance. At issue in this evidentiary hearing is whether the scientific literature provides a rational basis for the federal classification of the plant as a substance with “a high potential for abuse,” “no currently accepted medical use,” and a “lack of accepted safety” for use under medical supervision. The federal government’s position was articulated in testimony provided by Dr. Bertha Madras, Professor

Read More
Oct 282014
 October 28, 2014
Doctors Testify In Federal Court That Marijuana Needs To Be Rescheduled

The fact that marijuana is a Schedule 1 drug is slap in the face to science, compassion, and logic. For something to be Schedule 1, it has to have no medical value. Marijuana clearly has medical value. This is proven by the fact that the federal government grows and supplies medical marijuana to four federal medical marijuana patients, and has for decades. The federal government also has medical marijuana patents. It may be the most hypocritical policy in government to say that marijuana should remain Schedule 1, and that’s saying a lot because the government is full of hypocrisy. Doctors

Read More